Varicose Veins Clinical Trial
Official title:
A Randomised Controlled Trial Investigating The Use Of Pelvic Vein Embolisation To Reduce Recurrent Varicose Veins Of The Legs In Women With Primary Varicose Veins And Associated Pelvic Venous Reflux.
The aim of this study is to identify whether the treatment of pelvic venous reflux (pelvic coil embolisaton) in females with leg varicose veins, who have a proven contribution to their leg varicose veins from pelvic reflux, have a reduction in recurrence after varicose vein surgery.
Varicose veins of the legs effect between 20 and 40% of the adult population in the UK.
Approximately 100,000 operations performed per year for varicose veins. Failure to treat
varicose veins results in 10 to 20% of patients deteriorating to skin damage or leg
ulceration. Recurrence rates following surgery vary that have been reported up to 70% at 10
years.
The commonest causes of recurrence are reported to be:
- neovascularisation (new vessel growth after treatment)
- missing veins at the initial operation
- perforator vein incompetence
- de novo reflux due to normal deterioration with age
Recent studies have shown that leg varicose veins can be caused by pelvic venous reflux and
that pelvic venous reflux is a cause of recurrent varicose veins. Previous published work
from our own unit has shown that approximately 20% of women who present with varicose veins
of the legs and who have had children previously have pelvic venous reflux on duplex
ultrasound that contribute to the venous reflux in the legs, causing the varicose veins.
Furthermore, a recent retrospective study from our own unit has suggested that failure to
treat pelvic venous reflux before treating leg varicose veins is a major cause of recurrent
varicose veins in up to a quarter of women.
However, despite this circumstantial evidence, there is no evidence to prove whether the
treatment of pelvic venous reflux confers any advantage on these patients in terms of
reduction in recurrence of their varicose veins in the future.
The treatment of pelvic venous reflux is currently by coil embolisation of the veins under
x-ray control. This procedure clearly has an additional cost over and above that of treating
the legs. Therefore it is essential to know whether the treatment of the pelvic veins in
these patients is any effect in reducing the recurrence of leg varicose veins.
To examine whether the addition of coil embolisation has significant benefits for patients,
female patients presenting with primary leg varicose veins with a duplex proven contribution
from pelvic venous reflux will be randomised to:
1. transjugular coil embolisation of pelvic veins followed by endovenous treatment of leg
recurrent varicose veins or
2. endovenous treatment of leg recurrent varicose veins alone
The impact of demographic factors, the severity of patient's symptoms(Aberdeen
questionnaire, CEAP and VCCS scores)and treatment history will be explored in addition to
the type of treatment received.
Patients will be followed up at six weeks, six months, one year, two years, three years,
four years and five years.
Assessments will be quality-of-life scoring (CIVIQ), symptom severity (Aberdeen
questionnaire, CEAP and VCCS scores), patient satisfaction and clinical examination
including clinical photographs, duplex ultrasonography.
In the presence of recurrent varicose veins, the source of these will also be classified
through the use of duplex ultrasonography.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02441881 -
Trial of Radiofrequency Thermo-ablation Treatments of Great Saphenous Varicose Veins (3-RF Study)
|
N/A | |
Completed |
NCT03283800 -
Copper Impact on Venous Insufficiency and Lipodermatosclerosis
|
N/A | |
Recruiting |
NCT02676908 -
Optimum Duration of Compression Stockings After Endovenous Varicose Vein Surgery
|
N/A | |
Withdrawn |
NCT01203397 -
Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment
|
Phase 3 | |
Withdrawn |
NCT01426035 -
Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate Cream In The Superficial Varicose Veins Treatment
|
Phase 3 | |
Recruiting |
NCT02054325 -
Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins
|
Phase 4 | |
Withdrawn |
NCT03601572 -
Hypnoanalgesia in Surgical and Endovenous Treatment of Varicosis
|
||
Completed |
NCT04933591 -
Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood
|
N/A | |
Active, not recruiting |
NCT02397226 -
Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery
|
N/A | |
Withdrawn |
NCT02936271 -
Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting
|
N/A | |
Terminated |
NCT02557542 -
Pilot RCT Evaluating a One Stop Vein Clinic
|
N/A | |
Completed |
NCT00758420 -
Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT00841178 -
Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT
|
N/A | |
Not yet recruiting |
NCT05508581 -
Microwaves Ablation of Varicose Veins
|
N/A | |
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Active, not recruiting |
NCT04339075 -
Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
|
||
Completed |
NCT03392753 -
Mechanochemical Ablation Compared to Cyanoacrylate Adhesive
|
N/A | |
Recruiting |
NCT04146168 -
Lake Washington Vascular VenaSealâ„¢ Post-Market Evaluation
|
||
Recruiting |
NCT02304146 -
Long-term Ultrasound Guided Foam Sclerotherapy Versus Classical Surgical Stripping Study
|
N/A | |
Completed |
NCT01231373 -
Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
|
Phase 3 |